Immatics N.V. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ALXO
|
ALX Oncology Holdings Inc. | $1.96 | $469.42 M | -2.43 | 81 | $0 |
 AVTE
|
Aerovate Therapeutics, Inc. | $2.08 | $597.48 M | -6.84 | 51 | $0 |
 BCAB
|
BioAtla, Inc. | $1.63 | $73.14 M | -0.61 | 65 | $0 |
 CRNX
|
Crinetics Pharmaceuticals, Inc. | $50.71 | $3.53 B | -11.86 | 290 | $4.01 M |
 EWTX
|
Edgewise Therapeutics, Inc. | $26.07 | $1.65 B | -11.47 | 97 | $0 |
 FENC
|
Fennec Pharmaceuticals Inc. | $5.19 | $187.43 M | 171.5 | 29 | $21.64 M |
 HRMY
|
Harmony Biosciences Holdings, Inc. | $39.13 | $1.73 B | 13.15 | 246 | $582.02 M |
 INBX
|
Inhibrx Biosciences, Inc. | $15.55 | $241.02 M | -1.44 | 166 | $1.80 M |
 JANX
|
Janux Therapeutics, Inc. | $46.25 | $2.29 B | -36.8 | 69 | $8.08 M |
 KRON
|
Kronos Bio, Inc. | $0.98 | $44.62 M | -0.37 | 58 | $6.29 M |
 KROS
|
Keros Therapeutics, Inc. | $56.50 | $1.76 B | -9.45 | 149 | $151,000 |
 LYEL
|
Lyell Immunopharma, Inc. | $1.50 | $619.50 M | -2.7 | 224 | $130,000 |
 MLYS
|
Mineralys Therapeutics, Inc. | $11.91 | $652.38 M | -6.03 | 28 | $0 |
 MRUS
|
Merus N.V. | $47.76 | $3.50 B | -19.38 | 172 | $43.95 M |
 REPL
|
Replimune Group, Inc. | $11.16 | $485.18 M | -2.44 | 331 | $0 |
 SNDX
|
Syndax Pharmaceuticals, Inc. | $18.90 | $1.66 B | -6.02 | 184 | $0 |